Glynis Tavares

Glynis Tavares has a diverse work experience spanning several industries. Glynis is currently working as the Senior Director of Compliance at Avadel Pharmaceuticals plc since February 2023. Prior to this, they worked at TherapeuticsMD from September 2016 to February 2023, where they held the role of Director of Commercial Compliance and was involved in developing and commercializing healthcare products for women.

Before joining TherapeuticsMD, Glynis worked at Noven Pharmaceuticals from 2003 to 2016. During their tenure, they held multiple roles including Associate Director of Commercial Compliance and Senior Manager of Sample Accountability and Marketing Compliance. In these roles, they implemented programs to ensure compliance with regulations and strengthened sample practices.

Glynis started their career at the Federal Reserve Bank in 1999 as a Senior Financial Operations Analyst, where they evaluated operational efficiencies and provided analytical support for various projects. Prior to that, they worked as a Project Manager for Managed Care at John Alden from 1992 to 1999.

Overall, Glynis Tavares has gained extensive experience in compliance, commercialization, and project management throughout their career.

Glynis Tavares holds a Master of Business Administration (MBA) degree from Nova Southeastern University, which they obtained between 1999 and 2001. Glynis then pursued a Healthcare Compliance Certification from Seton Hall University School of Law, starting in 2011 with no specified end year. Prior to these achievements, Glynis earned a Bachelor of Business Administration (BBA) degree with a focus on Marketing from the University of Miami Herbert Business School; however, the exact dates of their enrollment are unknown. Additionally, Glynis has professional certifications, including a Managed Care Designation from the Health Insurance Association of America (HIAA) and a Fellow Life Management Institute (FLMI) Designation from the Life Office Management Association (LOMA), though the specific periods of obtaining these certifications are undisclosed.